Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05353673Phase 2Unknown
The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Blood Coagulation DisordersImmune ThrombocytopeniaPhysiological Effects of Drugs+1 more
PrincipalinvestigatorStart date: 2021-06-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peking University People's Hospital, Peking University Insititute of Hematology

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Kuter, MD

Massachusetts General Hospital

Related
5 trials

Shared therapeutic areas:

Blood Coagulation DisordersPurpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score23%

Joseph Kiss, MD

University of Pittsburgh

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score15%

Jeffrey McCullough, MD

University of Minnesota

Related
5 trials

Shared therapeutic areas:

ThrombocytopeniaBlood Coagulation Disorders
Similarity Score15%

Thomas Ortel, MD, PhD

Duke University

Related
3 trials

Shared therapeutic areas:

Blood Coagulation DisordersThrombocytopenia
Similarity Score15%

Barbara Konkle, MD

University of Pennsylvania

Related
3 trials

Shared therapeutic areas:

Blood Coagulation DisordersThrombocytopenia
Similarity Score15%

Ellis Neufeld, MD

Boston Children's Hospital

Related
6 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score15%

Judith Lin, MD

Brigham and Women's Hospital

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score15%

Ann Zimrin, MD

University of Maryland

Related
2 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score15%

Cindy Leissinger, MD

Tulane University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score15%

Terry Gernsheimer, MD

University of Washington

Related
4 trials

Shared therapeutic areas:

ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05471050Phase 2PrincipalInvestigator

The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia
Unknown
NCT05353673Phase 2PrincipalInvestigator

The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Blood Coagulation DisordersImmune ThrombocytopeniaPhysiological Effects of Drugs+1 more
Unknown

All 2 trials loaded